ResMed is a global manufacturer of CPAP masks, machines and other products that diagnose, treat or help manage sleep-disordered breathing (particularly sleep apnea), chronic obstructive pulmonary disease (COPD), or other respiratory conditions. For the general public, the company offers a non-contact sleep monitor, the S+ by ResMed, currently available in the US.

Wikipedia
ResMed
ResMed
YouTube Video
  • Holger Woehrle, MD. clarifies what ehealth, mhealth and patient engagements tools are. Sharing insights of a big data analysis from a German homecare provider, he illustrates the influence of a real time feedback patient engagement tool on adherence to positive airway pressure therapy. Telehealth solutions and patient engagement tools can improve therapy acceptance and compliance. Holger Woehrle, ...

ResMed
ResMed
YouTube Video
  • Professor Jean-Louis Pépin explains the findings of the study “Adherence to positive airway therapy after switching from CPAP to ASV: a big data analysis”. The analysis found that switching CPAP patients with persistent or emergent CSA from CPAP to ASV therapy may improve compliance. There was a +22% adherence improvement in the two patient subgroups that switched from CPAP to either fixed (n = 12...

ResMed
ResMed
YouTube Video
  • Holger Woerhle, MD, explains the main findings of a big data analysis on CSA during CPAP therapy. The analysis was able to identify 3 categories of CSA during CPAP therapy, all of which negatively affected CPAP therapy compliance and increased therapy termination risk. A second analysis performed on the same database found that switching patients with persistent or emergent CSA from CPAP to ASV th...

ResMed
ResMed
YouTube Video
  • Professor Jean-Louis Pépin gives a quick overview of Central Sleep Apnoea (CSA) today. After going through the taxonomy of CSA, he presents a systematic review on prevalence and risk factors associated with treatment emergent central sleep apnea and the challenges in the management of these patients. Jean-Louis Pépin, Professor of Physiology, University Hospital of Grenoble, France For more info...

ResMed
ResMed
YouTube Video
  • Professor Jean-Louis Pépin offers a summary of a big data analysis on CSA/CompSA. The analysis was able to identify 3 categories of CSA during CPAP therapy, all of which negatively affected CPAP therapy compliance and increased therapy termination risk. A second analysis performed on the same database, found that switching patients with persistent or emergent CSA from CPAP to ASV therapy may impr...

ResMed
ResMed
YouTube Video
  • Professor Jean-Louis Pépin explains the findings of the big data analysis “Trajectories of Emergent Central Sleep Apnea During CPAP therapy”. The analysis was able to identify 3 categories of CSA during CPAP therapy, all of which negatively affected CPAP therapy compliance and increased therapy termination risk. CompSA occurred in 3.5% of patients; 3 categories of CompSA were identified: emergent ...

ResMed
ResMed
YouTube Video
  • Ramon Farré, PhD, shares perspectives regarding big data: definition, new analytical concepts and tools, patient privacy protection, regulatory perspective and risks. He focuses on recent big data findings in the field of Sleep-Disordered Breathing. Professor Ramon Farré, Professor of Biomechanics, University of Barcelona, Spain For more information visit https://resmed.com/asv

ResMed
ResMed
Page Design Update

Careers at ResMed | Search Jobs and Apply Online | Make a Difference at ResMed

Before ResMed | Careers Home
After Careers at ResMed | Search Jobs and Apply Online | Make a Difference at ResMed

Out-Market Your Competitors?

Get complete competitive insights on over 2.2 million companies to drive your marketing strategy.

Create Free Account Log in

By signing up, you agree to the Terms of Service and Privacy Policy.

Out-Market Your Competitors

Get complete competitive insights on over 2.2 million companies to drive your marketing strategy.

Create Free Account

Already a user?  Log in

By signing up, you agree to the Terms of Service and Privacy Policy.